Literature DB >> 6362856

Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.

P Briand, A E Lykkesfeldt.   

Abstract

The human breast cancer cell line MCF-7 has been adapted to long-term growth at 0.5 and 0.05% fetal bovine serum. Free cytoplasmic and filled nuclear estrogen receptors were found in cells grown at 5, 0.5, and 0.05% fetal bovine serum. Cells grown in medium with 0.05% dextran-charcoal-treated serum contained cytoplasmic receptors but no filled nuclear receptors, indicating that this medium did not contain biologically active concentrations of estrogen. Addition of estradiol to the medium translocated the cytoplasmic receptor to the nucleus and stimulated progesterone receptor synthesis but did not increase the growth rate. The antiestrogen tamoxifen (TAM) inhibited cell growth at all serum concentrations investigated, at least in part by a reduction of the growth fraction. The sensitivity to TAM was highest at low serum concentrations. The effect of TAM could be reversed by estradiol at TAM concentrations of 10(-6) M or lower. It is concluded that estradiol does not have a direct growth-stimulatory effect on our MCF-7 cells in monolayer cultures although the cells contain functional estrogen receptors and growth of the cells in athymic mice requires estrogens. TAM has an estrogen-competitive, inhibitory effect on the growth of MCF-7 cells at concentrations lower than 10(-6) M. At higher concentrations, the growth inhibition is unspecific and noncompetitive by estradiol.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6362856

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells.

Authors:  S Thrane; A M Pedersen; M B H Thomsen; T Kirkegaard; B B Rasmussen; A K Duun-Henriksen; A V Lænkholm; M Bak; A E Lykkesfeldt; C W Yde
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

2.  The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer.

Authors:  V Thewes; R Simon; M Hlevnjak; M Schlotter; P Schroeter; K Schmidt; Y Wu; T Anzeneder; W Wang; P Windisch; M Kirchgäßner; N Melling; N Kneisel; R Büttner; U Deuschle; H P Sinn; A Schneeweiss; S Heck; S Kaulfuss; H Hess-Stumpp; J G Okun; G Sauter; A E Lykkesfeldt; M Zapatka; B Radlwimmer; P Lichter; M Tönjes
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

3.  Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen.

Authors:  P E Budtz
Journal:  Cell Prolif       Date:  1999-10       Impact factor: 6.831

4.  A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium.

Authors:  P Briand; O W Petersen; B Van Deurs
Journal:  In Vitro Cell Dev Biol       Date:  1987-03

5.  Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells.

Authors:  Nikolaos Svoronos; Alfredo Perales-Puchalt; Michael J Allegrezza; Melanie R Rutkowski; Kyle K Payne; Amelia J Tesone; Jenny M Nguyen; Tyler J Curiel; Mark G Cadungog; Sunil Singhal; Evgeniy B Eruslanov; Paul Zhang; Julia Tchou; Rugang Zhang; Jose R Conejo-Garcia
Journal:  Cancer Discov       Date:  2016-09-30       Impact factor: 39.397

6.  Biological differences among MCF-7 human breast cancer cell lines from different laboratories.

Authors:  C K Osborne; K Hobbs; J M Trent
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

7.  Role of serum and hormones during the growth and development of rat mammary tumor epithelial cells in collagen gel culture.

Authors:  D K Sinha; J E Pazik
Journal:  In Vitro Cell Dev Biol       Date:  1986-09

8.  The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.

Authors:  Alyson A Fiorillo; Terry R Medler; Yvonne B Feeney; Suzanne M Wetz; Kalie L Tommerdahl; Charles V Clevenger
Journal:  Am J Pathol       Date:  2012-11-14       Impact factor: 4.307

9.  The influence of a novel cyclopropyl antiestrogen (compound 7a) on human breast cancer cells in culture.

Authors:  P T Jain; J T Pento; R A Magarian
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Cell cycle synchronization induced by tamoxifen and 17 beta-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine.

Authors:  S Bruno; A Di Vinci; E Geido; W Giaretti
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.